As of 2024-12-13, the EV/EBITDA ratio of Alignment Healthcare Inc (ALHC) is -21.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALHC's latest enterprise value is 2,003.40 mil USD. ALHC's TTM EBITDA according to its financial statements is -94.59 mil USD. Dividing these 2 quantities gives us the above ALHC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 15.3x | 14.4x |
| Forward P/E multiples | 16.2x - 17.9x | 17.0x |
| Fair Price | (7.31) - (6.90) | (7.09) |
| Upside | -165.8% - -162.0% | -163.8% |
| Date | EV/EBITDA |
| 2024-12-11 | -22.42 |
| 2024-12-10 | -22.17 |
| 2024-12-09 | -21.81 |
| 2024-12-06 | -21.73 |
| 2024-12-05 | -23.37 |
| 2024-12-04 | -24.02 |
| 2024-12-03 | -24.08 |
| 2024-12-02 | -24.67 |
| 2024-11-29 | -24.20 |
| 2024-11-27 | -24.65 |
| 2024-11-26 | -23.51 |
| 2024-11-25 | -23.75 |
| 2024-11-22 | -23.07 |
| 2024-11-21 | -23.17 |
| 2024-11-20 | -22.86 |
| 2024-11-19 | -21.12 |
| 2024-11-18 | -21.27 |
| 2024-11-15 | -21.92 |
| 2024-11-14 | -24.65 |
| 2024-11-13 | -24.54 |
| 2024-11-12 | -25.32 |
| 2024-11-11 | -25.92 |
| 2024-11-08 | -26.35 |
| 2024-11-07 | -26.57 |
| 2024-11-06 | -27.32 |
| 2024-11-05 | -25.56 |
| 2024-11-04 | -25.58 |
| 2024-11-01 | -24.89 |
| 2024-10-31 | -23.77 |
| 2024-10-30 | -22.42 |
| 2024-10-29 | -22.38 |
| 2024-10-28 | -22.03 |
| 2024-10-25 | -21.02 |
| 2024-10-24 | -20.21 |
| 2024-10-23 | -20.01 |
| 2024-10-22 | -20.45 |
| 2024-10-21 | -19.82 |
| 2024-10-18 | -20.69 |
| 2024-10-17 | -21.81 |
| 2024-10-16 | -22.56 |
| 2024-10-15 | -20.65 |
| 2024-10-14 | -21.73 |
| 2024-10-11 | -21.85 |
| 2024-10-10 | -21.57 |
| 2024-10-09 | -21.61 |
| 2024-10-08 | -22.40 |
| 2024-10-07 | -20.63 |
| 2024-10-04 | -20.78 |
| 2024-10-03 | -20.67 |
| 2024-10-02 | -21.47 |